Developed by:
Registrat MAPI (France) / MAPI Consultancy

Objective:
The Chronic Treatment Acceptance Questionnaire (ACCEPT) is an instrument developed to describe the global acceptability of chronic treatment and its predictors.

Copyright:

Registrat MAPI. All Rights Reserved.

Reference publication:
Acceptability of long-term treatment: what is it and how can it be assessed? Marant.C, Longin J., Gauchoux R, Arnould B, Spizak C, Marrel A, Patrick DL, Van Ganse E Submitted for publication in journal: Pharmacoepidemiology and Drug Safety

Conditions of use:

1. Permission and Licensing

- User is firstly required to gain written permission to use the ACCEPT from Registrat MAPI by contacting the following person:

- User is then required to complete and sign MAPI Research Trust's User Agreement in which specific conditions required by the Authors are detailed.


2. Access fees:

 Authors' royalty fee:

The ACCEPT is free of royalty fees for academic and clinical use.

For industry sponsored research and other commercial uses: 1,000 €* per protocol/application + 500 €* per language-version requested.

Other specific conditions requested by the Authors are detailed in the User Agreement.

Distribution fees:

Distribution Fees are requested according to the study design and context of use of the questionnaire:

- In not-funded academic research (1) and individual clinical practice: free of charge
- In funded academic research (2): 300 €* per study + 50 €* per language-version  requested
- In commercial studies (3) involving "for-profit" organizations: 600 €* per study + 250 €* per language version requested

* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies).


Existing & New Translations:

Please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it for a list of existing translations of the ACCEPT (validated or not validated).

 Performing new translations
For the production of new translations to be used in commercial studies, each translation shall be coordinated by MAPI Institute.

Commercial and/or International studies
In order to undertake the linguistic validation of the ACCEPT questionnaire, funds are needed to support the whole translation process. Please contact the MAPI Institute at This e-mail address is being protected from spambots. You need JavaScript enabled to view it for an estimate of time and cost to translate/validate the needed version(s).

Academic translations / Not funded research and Evaluation studies
If funds are not available, ACCEPT translation guidelines will be provided to allow academics and clinicians to use the ACCEPT in their institution. The user will be required to sign a Translation Agreement which is available upon request from Mapi Research Trust.
 

Review copy / Original version:

US English version available for review purpose only. Please click here to access.


Contact information:

MAPI Research Trust

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 55 73
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust to the address above by post. As soon as we receive it, we will process your request.

More information on ACCEPT on PROQOLID [Sorry, no link - web page under construction] 

[ BACK ]